Table 1. Baseline demographics and characteristics for patients with meningioma (cohort 1) and without meningioma (cohort 2) before and after propensity score matching.
| Variable | Unmatched | Matched | ||
| Cohort 1: Meningioma, N (%) | Cohort 2: No meningioma, N (%) | Cohort 1: Meningioma, N (%) | Cohort 2: No meningioma, N (%) | |
| Patients (n) | 1,762 | 26,168 | 1,739 | 1,739 |
| Age at Index | 42.7 ± 17.5 | 32.1 ± 12.5 | 42.2 ± 17 | 42 ± 17.9 |
| Race | ||||
| White | 1,074 (60.95) | 13,029 (49.79) | 1,064 (61.19) | 1,092 (62.80) |
| Black | 325 (18.45) | 9,853 (37.65) | 324 (18.63) | 328 (18.86) |
| Asian | 3141 (7.82) | 2,551 (9.75) | 303 (17.42) | 271 (15.58) |
| Unknown | 39 (2.21) | 588 (2.25) | 38 (2.19) | 33 (1.90) |
| Comorbid Conditions | ||||
| Hypertension | 479 (27.19) | 5,287 (20.20) | 464 (26.68) | 439 (25.24) |
| Obesity | 286 (16.23) | 8,019 (30.64) | 286 (16.45) | 240 (13.80) |
| Diabetes Mellitus | 199 (11.29) | 3,066 (11.72) | 194 (11.16) | 190 (10.93) |
| Supervision of high-risk pregnancy | 300 (17.03) | 7,934 (30.32) | 300 (17.25) | 288 (13.80) |
| Migraine | 192 (10.90) | 2,952 (11.28) | 192 (11.04) | 166 (9.55) |
| Asthma | 194 (11.01) | 3,964 (15.15) | 194 (11.16) | 173 (9.95) |
| Epilepsy or recurrent seizures | 143 (8.12) | 522 (2.00) | 129 (7.42) | 115 (6.61) |
| Coagulation Disorders | 121 (6.87) | 1,118 (4.27) | 114 (6.56) | 114 (6.56) |
| Chronic Obstructive Pulmonary Disease | 82 (4.65) | 661 (2.53) | 79 (4.54) | 60 (3.45) |
| Systemic Lupus Erythematous | 13 (0.74) | 337 (1.29) | 12 (0.69) | 15 (0.86) |